← Back to patent-cliff list
CAS 38025-90-0
2-Chloro-6-hydroxynicotinic acid
Codes: (II)1114845-3-a
Application context (from source-drug indications)
Non-small cell lung cancerGarsorasibColorectal cancerGarsorasibSolid tumourGarsorasibRenal cell carcinomaGarsorasibPancreatic cancerGarsorasib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Garsorasib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2,6-Dichloronicotinic acid→2-Chloro-6-hydroxynicotinic acid→2,5-Dichloro-6-hydroxynicotinic acid→2,3,6-Trichloro-5-(trifluoromethyl)pyridine→2,5,6-Trichloronicotinic acid
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.